Percheron Therapeutics (ASX: PER) Share Price

PER

$0.004▼-11.11%

$4.5MRank #1704 on ASXHealthcareDrug Manufacturers - Specialty & Generic

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$4.5M

Volume

152K

P/E Ratio

-0.79

EPS

-$0.0029

Dividend Yield

0.00%

52-Week High

$0.013

52-Week Low

$0.004

Beta

1.013

Percheron Therapeutics (ASX: PER) is an Australian-listed company in the Healthcare sector with a market capitalisation of $4.5M and the 1704th-largest security on the ASX by market capitalisation. The PER share price is $0.004, down 11.11% today and down 60.00% over the past 12 months. Shares have traded between $0.004 and $0.013 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), Percheron Therapeutics reported revenue of $0 and a net loss of $3.1M.

Charts

$0.00

24H Range

$0.004

52-Week Range

$0.004

$0.013

About Percheron Therapeutics Limited

Percheron Therapeutics Limited, an Australian enterprise established in 2000 with its headquarters in Melbourne, is dedicated to the research and development of groundbreaking antisense pharmaceuticals. Formerly known as Antisense Therapeutics Limited until its name change in December 2023, the company holds a promising product portfolio. This includes ATL1102, an antisense inhibitor designed to target CD49d, which is currently undergoing Phase IIa clinical trials for the treatment of various inflammatory and muscular conditions such as Duchenne Muscular Dystrophy, Limb Girdle Muscular Dystrophy R2, multiple sclerosis, and asthma. Another key asset is Atesidorsen (ATL1103), an oligonucleotide that has finished Phase II clinical trials. Atesidorsen functions by blocking the growth hormone receptor, aiming to lower blood concentrations of insulin-like growth factor-I (IGF-I) and thereby address illnesses linked to an overabundance of growth hormone activity.

IPO Date

26 Dec 2023

CEO

James Garner

Employees

Website

percherontx.com

Key Financial Data

Revenue (Quarterly)	$0
Net Income (Quarterly)	$-3.1M
Total Assets	$7.9M
Total Debt	$10,682
Free Cash Flow	$-2.6M
Return on Equity	-43.51%
Profit Margin	—
Operating Margin	—

PER Frequently Asked Questions

What is the Percheron Therapeutics (ASX: PER) share price?

The PER share price is $0.004, down 11.11% for the day, based on the latest available ASX market data.

What is Percheron Therapeutics's market capitalisation?

Percheron Therapeutics has a market capitalisation of $4.5M, making it the 1704th-largest security listed on the ASX.

Does Percheron Therapeutics pay a dividend?

PER does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Percheron Therapeutics profitable?

In its most recent reported period (ending 31 Dec 2025), PER reported revenue of $0 and a net loss of $3.1M.

How many PER shares are on issue?

Percheron Therapeutics has approximately 1,114,063,500 shares on issue, based on its market capitalisation of $4.5M and current share price.

What sector is Percheron Therapeutics in?

Percheron Therapeutics is classified in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry on the ASX.

When did Percheron Therapeutics list on the ASX?

Percheron Therapeutics listed on the Australian Securities Exchange on 26 Dec 2023.

Latest News

Percheron presents ASCO data supporting HMBD-002's potential in hard-to-treat breast cancer

Proactive financial news2 June 2026

Percheron presents ASCO data supporting HMBD-002's potential in hard-to-treat breast cancer Proactive financial news

Insights: Percheron Therapeutics Ltd (ASX:PER)

smallcaps.com.au30 Oct 2025

Insights: Percheron Therapeutics Ltd (ASX:PER) smallcaps.com.au

Percheron Therapeutics (ASX:PER) Stock Analysis: Can This Biotech Rebound from All-Time Lows?

Kalkine30 Mar 2026

Percheron Therapeutics (ASX:PER) Stock Analysis: Can This Biotech Rebound from All-Time Lows? Kalkine

Percheron flags ASCO nod for HMBD-002 cancer therapy data

Proactive financial news30 Mar 2026

Percheron flags ASCO nod for HMBD-002 cancer therapy data Proactive financial news

Insider Buyers Lose AU$50k As Percheron Therapeutics Sheds AU$399k

Yahoo Finance17 Apr 2026

Insider Buyers Lose AU$50k As Percheron Therapeutics Sheds AU$399k Yahoo Finance

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
MEMMemphasys Limited	$17.1M	$0.006	-1.59	0.00%	–+0.00%
ICRIntelicare Holdings Limited	$10.9M	$0.023	0.00	0.00%	▼-2.13%
IXCInvex Therapeutics Ltd	$9.0M	$0.12	-3.15	0.00%	▲+31.87%
VBSVectus Biosystems Limited	$7.2M	$0.135	-3.28	0.00%	–+0.00%
ECSECS Botanics Holdings Ltd	$6.5M	$0.005	-2.57	0.00%	–+0.00%
BGTBio-Gene Technology Limited	$5.9M	$0.022	-1.25	0.00%	▲+10.00%
HIQHITIQ Limited	$5.0M	$0.01	-0.96	0.00%	–+0.00%
IVXInvion Limited	$4.3M	$0.044	-0.56	0.00%	–+0.00%

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.004	$0.004	$0.004	$0.004	152K	–+0.00%
11 June 2026	$0.004	$0.004	$0.004	$0.004	2M	–+0.00%
10 June 2026	$0.004	$0.004	$0.004	$0.004	796K	–+0.00%
9 June 2026	$0.004	$0.004	$0.004	$0.004	1.6M	▼-20.00%
8 June 2026	$0.005	$0.005	$0.004	$0.005	478K	▲+25.00%
5 June 2026	$0.005	$0.005	$0.004	$0.004	400K	–+0.00%
4 June 2026	$0.005	$0.005	$0.004	$0.004	476K	–+0.00%
3 June 2026	$0.005	$0.005	$0.004	$0.004	476K	–+0.00%
2 June 2026	$0.004	$0.005	$0.004	$0.004	335K	–+0.00%
1 June 2026	$0.005	$0.005	$0.004	$0.004	933K	–+0.00%
29 May 2026	$0.005	$0.005	$0.004	$0.004	3.8M	▼-20.00%
28 May 2026	$0.005	$0.005	$0.005	$0.005	5.8M	–+0.00%
27 May 2026	$0.005	$0.006	$0.005	$0.005	29M	▲+25.00%
26 May 2026	$0.004	$0.005	$0.004	$0.004	333K	–+0.00%
25 May 2026	$0.004	$0.004	$0.004	$0.004	824K	–+0.00%
22 May 2026	$0.004	$0.004	$0.004	$0.004	0	–+0.00%
21 May 2026	$0.004	$0.004	$0.004	$0.004	8.8K	–+0.00%
20 May 2026	$0.004	$0.004	$0.004	$0.004	3M	–+0.00%
19 May 2026	$0.004	$0.004	$0.004	$0.004	13K	–+0.00%
18 May 2026	$0.004	$0.004	$0.004	$0.004	10M	–+0.00%
15 May 2026	$0.004	$0.004	$0.004	$0.004	1M	–+0.00%
14 May 2026	$0.004	$0.004	$0.004	$0.004	70K	–+0.00%
13 May 2026	$0.004	$0.004	$0.004	$0.004	5.7K	–+0.00%
12 May 2026	$0.004	$0.004	$0.004	$0.004	1.7M	–+0.00%
11 May 2026	$0.004	$0.004	$0.004	$0.004	328K	–+0.00%
8 May 2026	$0.004	$0.004	$0.004	$0.004	1M	–+0.00%
7 May 2026	$0.004	$0.005	$0.004	$0.004	1.6M	–+0.00%
6 May 2026	$0.005	$0.005	$0.004	$0.004	1.1M	–+0.00%
5 May 2026	$0.004	$0.004	$0.004	$0.004	32K	▼-20.00%
4 May 2026	$0.005	$0.005	$0.005	$0.005	62K	–+0.00%

About Percheron Therapeutics Limited

IPO Date

26 Dec 2023

CEO

James Garner

Employees

Website

percherontx.com

PER Frequently Asked Questions

What is the Percheron Therapeutics (ASX: PER) share price?

The PER share price is $0.004, down 11.11% for the day, based on the latest available ASX market data.

What is Percheron Therapeutics's market capitalisation?

Percheron Therapeutics has a market capitalisation of $4.5M, making it the 1704th-largest security listed on the ASX.

Does Percheron Therapeutics pay a dividend?

PER does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Percheron Therapeutics profitable?

In its most recent reported period (ending 31 Dec 2025), PER reported revenue of $0 and a net loss of $3.1M.

How many PER shares are on issue?

Percheron Therapeutics has approximately 1,114,063,500 shares on issue, based on its market capitalisation of $4.5M and current share price.

What sector is Percheron Therapeutics in?

Percheron Therapeutics is classified in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry on the ASX.

When did Percheron Therapeutics list on the ASX?

Percheron Therapeutics listed on the Australian Securities Exchange on 26 Dec 2023.

Company

Market Cap

Price

P/E

Div Yield

1D Change

MEMMemphasys Limited

$17.1M

$0.006

-1.59

0.00%

–+0.00%

ICRIntelicare Holdings Limited

$10.9M

$0.023

0.00

0.00%

▼-2.13%

IXCInvex Therapeutics Ltd

$9.0M

$0.12

-3.15

0.00%

▲+31.87%

VBSVectus Biosystems Limited

$7.2M

$0.135

-3.28

0.00%

–+0.00%

ECSECS Botanics Holdings Ltd

$6.5M

$0.005

-2.57

0.00%

–+0.00%

BGTBio-Gene Technology Limited

$5.9M

$0.022

-1.25

0.00%

▲+10.00%

HIQHITIQ Limited

$5.0M

$0.01

-0.96

0.00%

–+0.00%

IVXInvion Limited

$4.3M

$0.044

-0.56

0.00%

–+0.00%

Company

Market Cap

Price

1Y Change

CSLCSL Limited

$51.49B

$107.51

▼-55.35%

RMDResMed Inc.

$40.21B

$27.72

▼-28.70%

SIGSigma Healthcare Limited

$30.48B

$2.64

▼-18.01%

FPHFisher & Paykel Healthcare Corporation Limited

$18.93B

$32.23

▼-5.74%

PMEPro Medicus Limited

$17.13B

$164.00

▼-41.41%

MPLMedibank Private Limited

$13.69B

$4.97

▲+1.22%

SHLSonic Healthcare Limited

$9.98B

$20.20

▼-24.66%

RHCRamsay Health Care Limited

$8.93B

$38.82

▲+5.16%

COHCochlear Limited

$6.79B

$103.75

▼-62.07%

TLXTelix Pharmaceuticals Limited

$4.61B

$13.60

▼-47.02%

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.004	$0.004	$0.004	$0.004	152K	–+0.00%
11 June 2026	$0.004	$0.004	$0.004	$0.004	2M	–+0.00%
10 June 2026	$0.004	$0.004	$0.004	$0.004	796K	–+0.00%
9 June 2026	$0.004	$0.004	$0.004	$0.004	1.6M	▼-20.00%
8 June 2026	$0.005	$0.005	$0.004	$0.005	478K	▲+25.00%
5 June 2026	$0.005	$0.005	$0.004	$0.004	400K	–+0.00%
4 June 2026	$0.005	$0.005	$0.004	$0.004	476K	–+0.00%
3 June 2026	$0.005	$0.005	$0.004	$0.004	476K	–+0.00%
2 June 2026	$0.004	$0.005	$0.004	$0.004	335K	–+0.00%
1 June 2026	$0.005	$0.005	$0.004	$0.004	933K	–+0.00%
29 May 2026	$0.005	$0.005	$0.004	$0.004	3.8M	▼-20.00%
28 May 2026	$0.005	$0.005	$0.005	$0.005	5.8M	–+0.00%
27 May 2026	$0.005	$0.006	$0.005	$0.005	29M	▲+25.00%
26 May 2026	$0.004	$0.005	$0.004	$0.004	333K	–+0.00%
25 May 2026	$0.004	$0.004	$0.004	$0.004	824K	–+0.00%
22 May 2026	$0.004	$0.004	$0.004	$0.004	0	–+0.00%
21 May 2026	$0.004	$0.004	$0.004	$0.004	8.8K	–+0.00%
20 May 2026	$0.004	$0.004	$0.004	$0.004	3M	–+0.00%
19 May 2026	$0.004	$0.004	$0.004	$0.004	13K	–+0.00%
18 May 2026	$0.004	$0.004	$0.004	$0.004	10M	–+0.00%
15 May 2026	$0.004	$0.004	$0.004	$0.004	1M	–+0.00%
14 May 2026	$0.004	$0.004	$0.004	$0.004	70K	–+0.00%
13 May 2026	$0.004	$0.004	$0.004	$0.004	5.7K	–+0.00%
12 May 2026	$0.004	$0.004	$0.004	$0.004	1.7M	–+0.00%
11 May 2026	$0.004	$0.004	$0.004	$0.004	328K	–+0.00%
8 May 2026	$0.004	$0.004	$0.004	$0.004	1M	–+0.00%
7 May 2026	$0.004	$0.005	$0.004	$0.004	1.6M	–+0.00%
6 May 2026	$0.005	$0.005	$0.004	$0.004	1.1M	–+0.00%
5 May 2026	$0.004	$0.004	$0.004	$0.004	32K	▼-20.00%
4 May 2026	$0.005	$0.005	$0.005	$0.005	62K	–+0.00%